Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01524614 · ClinicalTrials.gov registry record · NA

Safety Study of Continuous Positive Airway Pressure Via a Nasal Mask

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01524614: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01524614 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01524614, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Upper airway obstruction (UAO) is common complication during induction of general anesthesia. The mechanism of UAO during anesthesia has not been well understood. Posterior displacement of soft palate are believed to be the primary contributing factors. The mechanism of UAO during anesthesia share many similarities with obstructive sleep apnea (OSA). Since nasal continuous positive airway pressure (nCPAP) can maintain the airway patent in patients with OSA, the investigators hypothesize that nCPAP during induction of anesthesia will reduce the incidence and severity of UAO.

Interventions

  • PROCEDURE nasal mask

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2011-10
Est. Completion 2012-05
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01524614

The ClinicalTrials.gov registry entry for NCT01524614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which nasal mask is the first listed.

NCT01524614 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01524614 about?

NCT01524614 is a clinical study titled "Safety Study of Continuous Positive Airway Pressure Via a Nasal Mask". Upper airway obstruction (UAO) is common complication during induction of general anesthesia. The mechanism of UAO during anesthesia has not been well understood. Posterior displacement of soft palate are believed to be the primary contributing factors. The mechanism of UAO during anesthesia share m...

What is the current status of trial NCT01524614?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2011-10. Estimated completion is 2012-05.

What interventions are being tested in trial NCT01524614?

The interventions under investigation include: nasal mask (PROCEDURE).

Who is sponsoring clinical trial NCT01524614?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.